{"entity":{"type":"insider","cik":"0001410514","url":"/insider/0001410514","json_url":"/insider/0001410514.json","name":"Kelly Thomas Patrick","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":25,"first":"2007-08-22","last":"2024-02-20","span_basis":"filed_date"},"name_variants":[{"name":"Kelly Thomas Patrick","source":"filing","n_filings":25,"first_seen":"2007-08-22","last_seen":"2024-02-20"}],"transactions":[{"id":2458701,"accession":"0000950170-24-017091","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-017091","line_url":"/filing/0000950170-24-017091#line-2","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3010.0,"shares_display":"3,010","price_per_share":15.6177,"price_display":"15.62","price_state":"stated","total_value":47009.277,"total_display":"47,009.28","shares_owned_after":80350.0,"shares_owned_after_display":"80,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-02-20","scope":"insider"},{"id":2633909,"accession":"0000950170-24-005389","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-005389","line_url":"/filing/0000950170-24-005389#line-1","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2435.0,"shares_display":"2,435","price_per_share":14.4698,"price_display":"14.47","price_state":"stated","total_value":35233.963,"total_display":"35,233.96","shares_owned_after":66085.0,"shares_owned_after_display":"66,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-18","scope":"insider"},{"id":8282469,"accession":"0000950170-23-070384","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-070384","line_url":"/filing/0000950170-23-070384#line-2","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2792.0,"shares_display":"2,792","price_per_share":15.3671,"price_display":"15.37","price_state":"stated","total_value":42904.9432,"total_display":"42,904.94","shares_owned_after":68520.0,"shares_owned_after_display":"68,520","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-13","filed_date":"2023-12-14","scope":"insider"},{"id":8023571,"accession":"0001209191-23-053936","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-053936","line_url":"/filing/0001209191-23-053936#line-2","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2316.0,"shares_display":"2,316","price_per_share":12.0176,"price_display":"12.02","price_state":"stated","total_value":27832.7616,"total_display":"27,832.76","shares_owned_after":63068.0,"shares_owned_after_display":"63,068","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-30","filed_date":"2023-10-31","scope":"insider"},{"id":8652909,"accession":"0001209191-23-038755","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-038755","line_url":"/filing/0001209191-23-038755#line-1","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1655.0,"shares_display":"1,655","price_per_share":14.4018,"price_display":"14.40","price_state":"stated","total_value":23834.979,"total_display":"23,834.98","shares_owned_after":57140.0,"shares_owned_after_display":"57,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-16","filed_date":"2023-06-21","scope":"insider"},{"id":7867680,"accession":"0001209191-23-010519","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-010519","line_url":"/filing/0001209191-23-010519#line-2","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1370.0,"shares_display":"1,370","price_per_share":15.099,"price_display":"15.10","price_state":"stated","total_value":20685.63,"total_display":"20,685.63","shares_owned_after":58795.0,"shares_owned_after_display":"58,795","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-16","filed_date":"2023-02-17","scope":"insider"},{"id":8572996,"accession":"0001209191-23-003994","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-003994","line_url":"/filing/0001209191-23-003994#line-1","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2403.0,"shares_display":"2,403","price_per_share":21.2413,"price_display":"21.24","price_state":"stated","total_value":51042.8439,"total_display":"51,042.84","shares_owned_after":43677.0,"shares_owned_after_display":"43,677","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-19","scope":"insider"},{"id":6105649,"accession":"0001209191-22-038426","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-038426","line_url":"/filing/0001209191-22-038426#line-1","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1768.0,"shares_display":"1,768","price_per_share":10.75,"price_display":"10.75","price_state":"stated","total_value":19006.0,"total_display":"19,006.00","shares_owned_after":46080.0,"shares_owned_after_display":"46,080","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-16","filed_date":"2022-06-21","scope":"insider"},{"id":6668211,"accession":"0001209191-22-011357","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-011357","line_url":"/filing/0001209191-22-011357#line-1","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1368.0,"shares_display":"1,368","price_per_share":9.05,"price_display":"9.05","price_state":"stated","total_value":12380.4,"total_display":"12,380.40","shares_owned_after":47848.0,"shares_owned_after_display":"47,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-16","filed_date":"2022-02-18","scope":"insider"},{"id":4138052,"accession":"0001209191-21-012117","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-012117","line_url":"/filing/0001209191-21-012117#line-2","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":524.0,"shares_display":"524","price_per_share":48.87,"price_display":"48.87","price_state":"stated","total_value":25607.88,"total_display":"25,607.88","shares_owned_after":6516.0,"shares_owned_after_display":"6,516","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider"},{"id":2083559,"accession":"0001209191-20-050679","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-050679","line_url":"/filing/0001209191-20-050679#line-2","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":50.0121,"price_display":"50.01","price_state":"stated","total_value":150036.3,"total_display":"150,036.30","shares_owned_after":7040.0,"shares_owned_after_display":"7,040","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-14","filed_date":"2020-09-16","scope":"insider"},{"id":2083512,"accession":"0001209191-20-050076","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-050076","line_url":"/filing/0001209191-20-050076#line-6","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":47.7087,"price_display":"47.71","price_state":"stated","total_value":143126.1,"total_display":"143,126.10","shares_owned_after":7040.0,"shares_owned_after_display":"7,040","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-10","filed_date":"2020-09-10","scope":"insider"},{"id":2083508,"accession":"0001209191-20-050076","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-050076","line_url":"/filing/0001209191-20-050076#line-4","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":45.2295,"price_display":"45.23","price_state":"stated","total_value":167349.15,"total_display":"167,349.15","shares_owned_after":8540.0,"shares_owned_after_display":"8,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-08","filed_date":"2020-09-10","scope":"insider"},{"id":2083506,"accession":"0001209191-20-050076","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-050076","line_url":"/filing/0001209191-20-050076#line-3","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":46.5497,"price_display":"46.55","price_state":"stated","total_value":69824.55,"total_display":"69,824.55","shares_owned_after":7040.0,"shares_owned_after_display":"7,040","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-08","filed_date":"2020-09-10","scope":"insider"},{"id":2083504,"accession":"0001209191-20-050076","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-050076","line_url":"/filing/0001209191-20-050076#line-2","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":44.6944,"price_display":"44.69","price_state":"stated","total_value":35755.52,"total_display":"35,755.52","shares_owned_after":12240.0,"shares_owned_after_display":"12,240","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-08","filed_date":"2020-09-10","scope":"insider"},{"id":2076188,"accession":"0001209191-20-028784","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-028784","line_url":"/filing/0001209191-20-028784#line-3","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9395.0,"shares_display":"9,395","price_per_share":55.0842,"price_display":"55.08","price_state":"stated","total_value":517516.059,"total_display":"517,516.06","shares_owned_after":9645.0,"shares_owned_after_display":"9,645","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-11","filed_date":"2020-05-13","scope":"insider"},{"id":2076185,"accession":"0001209191-20-028784","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-028784","line_url":"/filing/0001209191-20-028784#line-2","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2605.0,"shares_display":"2,605","price_per_share":55.5563,"price_display":"55.56","price_state":"stated","total_value":144724.1615,"total_display":"144,724.16","shares_owned_after":7040.0,"shares_owned_after_display":"7,040","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-11","filed_date":"2020-05-13","scope":"insider"},{"id":2223973,"accession":"0001209191-20-001756","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-20-001756","line_url":"/filing/0001209191-20-001756#line-10","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2793.0,"shares_display":"2,793","price_per_share":57.2235,"price_display":"57.22","price_state":"stated","total_value":159825.2355,"total_display":"159,825.24","shares_owned_after":1066.0,"shares_owned_after_display":"1,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-03","filed_date":"2020-01-06","scope":"insider"},{"id":2223970,"accession":"0001209191-20-001756","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-20-001756","line_url":"/filing/0001209191-20-001756#line-9","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":966.0,"shares_display":"966","price_per_share":58.143,"price_display":"58.14","price_state":"stated","total_value":56166.138,"total_display":"56,166.14","shares_owned_after":100.0,"shares_owned_after_display":"100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-03","filed_date":"2020-01-06","scope":"insider"},{"id":2223967,"accession":"0001209191-20-001756","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-20-001756","line_url":"/filing/0001209191-20-001756#line-8","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":56.256,"price_display":"56.26","price_state":"stated","total_value":28128.0,"total_display":"28,128.00","shares_owned_after":3859.0,"shares_owned_after_display":"3,859","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-03","filed_date":"2020-01-06","scope":"insider"},{"id":2223963,"accession":"0001209191-20-001756","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-001756","line_url":"/filing/0001209191-20-001756#line-7","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":58.74,"price_display":"58.74","price_state":"stated","total_value":5874.0,"total_display":"5,874.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-03","filed_date":"2020-01-06","scope":"insider"},{"id":2223956,"accession":"0001209191-20-001756","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-001756","line_url":"/filing/0001209191-20-001756#line-5","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5360.0,"shares_display":"5,360","price_per_share":57.5388,"price_display":"57.54","price_state":"stated","total_value":308407.968,"total_display":"308,407.97","shares_owned_after":2281.0,"shares_owned_after_display":"2,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-06","scope":"insider"},{"id":2223953,"accession":"0001209191-20-001756","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-001756","line_url":"/filing/0001209191-20-001756#line-4","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1981.0,"shares_display":"1,981","price_per_share":58.162,"price_display":"58.16","price_state":"stated","total_value":115218.922,"total_display":"115,218.92","shares_owned_after":300.0,"shares_owned_after_display":"300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-06","scope":"insider"},{"id":2223949,"accession":"0001209191-20-001756","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-001756","line_url":"/filing/0001209191-20-001756#line-3","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":59.48,"price_display":"59.48","price_state":"stated","total_value":11896.0,"total_display":"11,896.00","shares_owned_after":100.0,"shares_owned_after_display":"100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-06","scope":"insider"},{"id":2223946,"accession":"0001209191-20-001756","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-001756","line_url":"/filing/0001209191-20-001756#line-2","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":62.25,"price_display":"62.25","price_state":"stated","total_value":6225.0,"total_display":"6,225.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-06","scope":"insider"},{"id":8520927,"accession":"0001209191-19-061918","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-061918","line_url":"/filing/0001209191-19-061918#line-2","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":68.2092,"price_display":"68.21","price_state":"stated","total_value":2728368.0,"total_display":"2,728,368.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-23","filed_date":"2019-12-26","scope":"insider"},{"id":8167807,"accession":"0001209191-19-054496","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-054496","line_url":"/filing/0001209191-19-054496#line-2","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3750.0,"shares_display":"3,750","price_per_share":40.0026,"price_display":"40.00","price_state":"stated","total_value":150009.75,"total_display":"150,009.75","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-28","filed_date":"2019-10-30","scope":"insider"},{"id":7884609,"accession":"0001209191-19-049467","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-049467","line_url":"/filing/0001209191-19-049467#line-3","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8160.0,"shares_display":"8,160","price_per_share":34.8005,"price_display":"34.80","price_state":"stated","total_value":283972.08,"total_display":"283,972.08","shares_owned_after":8160.0,"shares_owned_after_display":"8,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-11","filed_date":"2019-09-13","scope":"insider"},{"id":7884604,"accession":"0001209191-19-049467","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-049467","line_url":"/filing/0001209191-19-049467#line-2","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3090.0,"shares_display":"3,090","price_per_share":35.4265,"price_display":"35.43","price_state":"stated","total_value":109467.885,"total_display":"109,467.88","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-11","filed_date":"2019-09-13","scope":"insider"},{"id":8395584,"accession":"0001209191-19-045820","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-045820","line_url":"/filing/0001209191-19-045820#line-4","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7264.0,"shares_display":"7,264","price_per_share":40.6894,"price_display":"40.69","price_state":"stated","total_value":295567.8016,"total_display":"295,567.80","shares_owned_after":3986.0,"shares_owned_after_display":"3,986","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-13","filed_date":"2019-08-13","scope":"insider"},{"id":8395569,"accession":"0001209191-19-045820","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-045820","line_url":"/filing/0001209191-19-045820#line-3","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3586.0,"shares_display":"3,586","price_per_share":42.2534,"price_display":"42.25","price_state":"stated","total_value":151520.6924,"total_display":"151,520.69","shares_owned_after":400.0,"shares_owned_after_display":"400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-13","filed_date":"2019-08-13","scope":"insider"},{"id":8395562,"accession":"0001209191-19-045820","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-045820","line_url":"/filing/0001209191-19-045820#line-2","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":42.9175,"price_display":"42.92","price_state":"stated","total_value":17167.0,"total_display":"17,167.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-13","filed_date":"2019-08-13","scope":"insider"},{"id":8392058,"accession":"0001209191-19-038450","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-038450","line_url":"/filing/0001209191-19-038450#line-2","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":177.0,"shares_display":"177","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":4425.0,"total_display":"4,425.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-19","filed_date":"2019-06-21","scope":"insider"},{"id":8100609,"accession":"0001209191-19-034713","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-034713","line_url":"/filing/0001209191-19-034713#line-2","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":25.2033,"price_display":"25.20","price_state":"stated","total_value":52926.93,"total_display":"52,926.93","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-03","filed_date":"2019-06-05","scope":"insider"},{"id":7926870,"accession":"0001209191-19-032277","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-032277","line_url":"/filing/0001209191-19-032277#line-4","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":2500.0,"total_display":"2,500.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-22","filed_date":"2019-05-23","scope":"insider"},{"id":7926863,"accession":"0001209191-19-032277","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-032277","line_url":"/filing/0001209191-19-032277#line-2","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1373.0,"shares_display":"1,373","price_per_share":25.0683,"price_display":"25.07","price_state":"stated","total_value":34418.7759,"total_display":"34,418.78","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-21","filed_date":"2019-05-23","scope":"insider"},{"id":8490842,"accession":"0001209191-19-027308","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-027308","line_url":"/filing/0001209191-19-027308#line-2","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13500.0,"shares_display":"13,500","price_per_share":22.9277,"price_display":"22.93","price_state":"stated","total_value":309523.95,"total_display":"309,523.95","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-01","filed_date":"2019-05-03","scope":"insider"},{"id":8485633,"accession":"0001209191-19-011841","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-011841","line_url":"/filing/0001209191-19-011841#line-2","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":45000.0,"total_display":"45,000.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-19","filed_date":"2019-02-20","scope":"insider"},{"id":7920213,"accession":"0001209191-19-003079","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-003079","line_url":"/filing/0001209191-19-003079#line-2","is_derivative":false,"issuer_cik":"0001410514","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001410514","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":25.18,"price_display":"25.18","price_state":"stated","total_value":125900.0,"total_display":"125,900.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-07","filed_date":"2019-01-09","scope":"insider"},{"id":8238594,"accession":"0001209191-07-050020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-050020","line_url":"/filing/0001209191-07-050020#line-1","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001410514","owner_name":"Kelly Thomas Patrick","owner_url":"/insider/0001410514","role":"Officer (CFO & SVP Finance & Corp. Dev)","officer_title":"CFO & SVP Finance & Corp. Dev,","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":2.0799,"price_display":"2.08","price_state":"stated","total_value":8319.6,"total_display":"8,319.60","shares_owned_after":30700.0,"shares_owned_after_display":"30,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-22","filed_date":"2007-08-22","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":40,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":39,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":40},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001654151","name":"Deciphera Pharmaceuticals, Inc.","url":"/issuer/0001654151","role":"Officer (Chief Financial Officer)","n_filings":24,"first_seen":"2019-01-09","last_seen":"2024-02-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001145404","name":"CRITICAL THERAPEUTICS INC","url":"/issuer/0001145404","role":"Officer (CFO & SVP Finance & Corp. Dev)","n_filings":1,"first_seen":"2007-08-22","last_seen":"2007-08-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001410514","retrieved_at":"2026-08-21T08:35:14+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}